Gastroenterologygut healthimmunity
Probiotics and Prebiotics: Unlocking the Secrets of Gut Health and Immunity
By MedXY|Dec 25, 2025
Explore how probiotics and prebiotics fortify gut health, boosting immune response and overall well-being.
Infectious Diseases
Latest news
300 articles · 20 / page
Infectious DiseasesDiarrheapneumonia
Norfloxacin, Levofloxacin, Moxifloxacin: 3 Minutes to Understand the Differences, Misuse Harms Your Health!
By MedXY|Oct 1, 2025
“Take Norfloxacin for diarrhea, Levofloxacin for urinary tract infections, and Moxifloxacin for pneumonia” – this…
Clinical UpdateseffectivenessHIV
Real-World Safety and Effectiveness of MVA-BN Vaccination Against Mpox: Evidence from German, Systematic Review, and Immunogenicity Cohorts
By MedXY|Oct 1, 2025
MVA-BN vaccination is safe and effective against mpox in at-risk populations, but reduced protection is noted in people living with HIV. Dose strategies and patient immunological status may affect outcomes.
Clinical Updatesantimicrobial stewardshiprandomized trial
Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial
By MedXY|Oct 1, 2025
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.
Clinical UpdatesPrimaquine
Efficacy and Safety of High-Dose Versus Low-Dose Primaquine for Plasmodium vivax in Cambodia: A Randomised Controlled Trial
By MedXY|Oct 1, 2025
A Cambodian study shows that a 14-day high-dose primaquine regimen (7.0 mg/kg) significantly reduces Plasmodium vivax relapse compared to the standard low-dose (3.5 mg/kg), with comparable safety in G6PD-normal patients.
Clinical Updatesantibiotic resistancemigrant health
Corynebacterium diphtheriae Outbreak among Migrants in Europe: Clinical, Epidemiologic, and Microbiologic Insights
By MedXY|Sep 30, 2025
A multicountry outbreak of diphtheria among migrants in Europe raised concerns about cutaneous and respiratory disease, cross-border spread, and emerging antibiotic resistance. Genomic analysis revealed multiclonal transmission and resistan
Infectious Diseasescluster-randomized trialivermectin
Mass Ivermectin Administration for Malaria Control: Translational Insights from Recent Cluster-Randomized Trials
By MedXY|Sep 30, 2025
Recent cluster-randomized trials in Kenya and Burkina Faso provide mixed but informative evidence on the efficacy and safety of mass ivermectin administration for malaria control, highlighting both its potential and limitations.
Clinical UpdatesClostridioides difficile
Fecal Microbiota Transplantation versus Vancomycin in Primary Clostridioides difficile Infection: A Noninferiority Randomized Trial
By MedXY|Sep 30, 2025
FMT is noninferior to vancomycin for primary CDI, with similar cure rates and safety, suggesting it may be a viable first-line therapy.
Clinical Updatesneuroinvasive diseaseprevention
West Nile Virus: Clinical Burden, Diagnostic Challenges, and Prevention in the U.S.
By MedXY|Sep 30, 2025
West Nile virus is the leading mosquito-borne disease in the U.S., causing significant neuroinvasive morbidity and mortality, especially in older and immunocompromised individuals. With no approved treatments or vaccines, prevention and sur
Clinical Updatesbimekizumab
Dual IL-17A/F Blockade and Increased Candidiasis Risk
By MedXY|Sep 30, 2025
Blocking both IL-17A and IL-17F impairs neutrophil migration, reducing antifungal defense and raising candidiasis risk in patients on bimekizumab, according to in vitro evidence.
Gastroenterologyclinical trialsgastroenteritis
Is There a Norovirus Vaccine on the Horizon? Scientific Progress, Challenges, and Future Directions
By MedXY|Sep 30, 2025
Norovirus vaccines show promise in clinical trials, but scientific and logistical challenges remain. No approved vaccine exists yet, though novel approaches, including oral pills, are advancing development.
Clinical Updatesinfluenzaneurology
Influenza-Associated Acute Necrotizing Encephalopathy in US Children
By MedXY|Sep 30, 2025
A multicenter US study highlights the devastating burden of influenza-associated acute necrotizing encephalopathy in children, with high mortality and disability rates despite aggressive therapy, underscoring the urgent need for prevention
Clinical Updatesantifungal resistance
Rising Threat: Triazole-Resistant Aspergillus fumigatus and the Challenge of Fungal Antimicrobial Resistance
By MedXY|Sep 30, 2025
A 29-year genomic study reveals increasing genetic diversity and prevalence of triazole-resistant Aspergillus fumigatus, raising concerns for clinical management and highlighting the need for novel diagnostics and antifungal strategies.
Infectious DiseasesHepatitis CPediatrics
Low Hepatitis C Treatment Rates in Children: Understanding the Barriers and Opportunities
By MedXY|Sep 30, 2025
A study published in Pediatrics reveals low rates of hepatitis C treatment among children, highlighting significant racial disparities and access challenges.
Infectious Diseasesinfectious diseasespublic health
Why Do New Infectious Diseases Keep Emerging? Understanding the Comeback and Evolution of Pathogens
By MedXY|Sep 30, 2025
New infectious diseases continue to emerge and old ones resurge due to evolving pathogens, environmental changes, and global interconnectedness. Understanding these dynamics is key to prevention and response.
Infectious Diseaseshuman healthinfectious disease
Are We Winning or Losing the Battle Against Viruses and Microbes?
By MedXY|Sep 30, 2025
A deep dive into humanity’s ongoing struggle with viruses and microbes—what science reveals, common myths, and how we can best protect ourselves.
Family Medicine & NutritionallergiesAntibiotics
Antibiotic Use Before Age Two May Increase Allergy Risk, Study Finds
By MedXY|Dec 25, 2025
Research presented at the European Respiratory Society’s annual meeting links early antibiotic use in children to increased allergy risks such as eczema and hay fever.
Infectious Diseasesantibiotic resistanceinfectious disease
The Invisible Enemy: Are Superbugs Winning the War on Antibiotics?
By MedXY|Sep 30, 2025
Antibiotic resistance is growing worldwide, threatening our ability to treat common infections. Discover the science, misconceptions, and what we can all do to combat superbugs.
Diabetes & Endocrinologylong COVIDobesity
Impact of Obesity on Long COVID: Insights from Primate Studies
By MedXY|Sep 30, 2025
Obesity influences the long-term effects of SARS-CoV-2, revealing diverse outcomes in primates and suggesting broader implications for humans.
Emergency Medicine
“Urgent Alert: Fatal Brain Infection Linked to Nasal Irrigation in Elderly Woman”
By MedXY|Dec 25, 2025
Title: When Routine Health Practices Turn Risky: A Closer Look at Nasal Irrigation and Primary…
Browse by specialty
Open language-specific specialty feeds and department pages.